A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients
Clinical trial NCT01305239 · TERMINATED
Trial details
- NCT number
- NCT01305239
- Sponsor
- Pfizer
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2008-10-01
- Primary completion
- 2011-05-01
- Enrollment
- 398
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.